Talphera (NASDAQ:TLPH) Trading Down 2.7% – Here’s What Happened

Talphera, Inc. (NASDAQ:TLPH) was down 2.7% on Monday . The stock traded as low as $1.04 and last traded at $1.07. Approximately 189,221 shares were traded during mid-day trading, a decline of 55% from the average daily volume of 416,292 shares. The stock had previously closed at $1.10.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Talphera in a report on Wednesday, October 8th. Wall Street Zen raised shares of Talphera to a “hold” rating in a research report on Saturday, November 1st. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $5.00.

Talphera Stock Performance

The company has a market cap of $49.87 million, a price-to-earnings ratio of -2.82 and a beta of 0.25. The company’s fifty day moving average is $1.23 and its two-hundred day moving average is $0.85.

Talphera (NASDAQ:TLPH) last released its quarterly earnings data on Wednesday, November 12th. The company reported ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.01. On average, sell-side analysts anticipate that Talphera, Inc. will post -0.64 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. AIGH Capital Management LLC acquired a new position in Talphera in the third quarter valued at approximately $3,979,000. Rosalind Advisors Inc. grew its stake in shares of Talphera by 118.9% during the 3rd quarter. Rosalind Advisors Inc. now owns 4,385,757 shares of the company’s stock worth $3,917,000 after purchasing an additional 2,381,818 shares during the period. Nantahala Capital Management LLC increased its holdings in shares of Talphera by 75.3% during the 3rd quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company’s stock valued at $3,120,000 after purchasing an additional 1,500,000 shares in the last quarter. Dauntless Investment Group LLC purchased a new position in shares of Talphera during the 3rd quarter valued at approximately $89,000. Finally, Virtu Financial LLC acquired a new position in shares of Talphera in the 3rd quarter valued at $29,000. 37.67% of the stock is currently owned by hedge funds and other institutional investors.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.